http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1254270-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D267-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-14 |
| filingDate | 1970-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1971-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1254270-A |
| titleOfInvention | Benzoxazepine derivatives |
| abstract | 1,254,270. Benzoxazepine derivatives. SUMITOMO CHEMICAL CO. Ltd. 26 March, 1970 [28 March, 1969; 31 March, 1969; 6 May, 1969], No. 14968/70. Heading C2C. Novel compounds of Formulµ I and IT: in which each of X 1 and X 2 is H, halogen, C 1-3 alkyl or C 1-3 alkoxy) and acid addition salts thereof, are prepared by contacting a compound of Formula III: with a dehydrating agent at an elevated temperature to form a compound of Formula I, if necessary reducing this compound to form a compound of Formula II and, if desired, forming an acid addition salt of a compound of Formula I or II. Starting materials of Formula III are prepared by reacting a compound of Formula IV: with a compound of Formula V: (in which Y is halogen). Pharmaceutical compositions having central nervous system activity, for oral or parenteral administration, comprise a compound of Formula I or II, or a pharmaceutically acceptable acid addition salt thereof, together with a pharmaceutically acceptable carrier. |
| priorityDate | 1969-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17900740 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419742051 |
Total number of triples: 12.